The Ebola vaccine market is estimated to be valued at US$ 5.83 Bn in 2023 and is expected to exhibit a CAGR of 32% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Ebola vaccine market consists of vaccines that provide protection against Ebola virus infection. Ebola virus causes a severe hemorrhagic fever in humans...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian